Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon M Lanzo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|July 22, 2022
Excreted 99m Tc-Pertechnetate in a Renal Pelvis as a Potential False Positive in a Meckel's ScanShannon M Lanzo, Austin R Pantel, Hongming Zhuang
Radiographics : a Review Publication of the Radiological Society of North America, Inc|February 23, 2023
<sup>18</sup>F-Fluoroestradiol: Current Applications and Future DirectionsSophia R O'Brien, Christine E Edmonds, Shannon M Lanzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|July 22, 2022
Excreted 99m Tc-Pertechnetate in a Renal Pelvis as a Potential False Positive in a Meckel's ScanShannon M Lanzo, Austin R Pantel, Hongming Zhuang
Radiographics : a Review Publication of the Radiological Society of North America, Inc|February 23, 2023
<sup>18</sup>F-Fluoroestradiol: Current Applications and Future DirectionsSophia R O'Brien, Christine E Edmonds, Shannon M Lanzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 1